- Clinical Trials
- February 2025
- 819 Pages
Global
From €3130EUR$3,450USD£2,698GBP
- Clinical Trials
- February 2025
- 107 Pages
Global
From €3130EUR$3,450USD£2,698GBP
- Report
- February 2025
- 135 Pages
Global
From €16326EUR$17,995USD£14,070GBP
- Report
- January 2025
- 62 Pages
Global
From €3171EUR$3,495USD£2,733GBP
- Report
- January 2025
- 99 Pages
Global
From €3171EUR$3,495USD£2,733GBP
- Report
- December 2024
- 47 Pages
Global
From €9068EUR$9,995USD£7,815GBP
- Report
- December 2024
- 84 Pages
Global
From €3171EUR$3,495USD£2,733GBP
- Report
- December 2024
- 66 Pages
Global
From €3171EUR$3,495USD£2,733GBP
- Report
- December 2024
- 66 Pages
Global
From €3171EUR$3,495USD£2,733GBP
- Report
- November 2024
- 78 Pages
Global
From €3171EUR$3,495USD£2,733GBP
- Report
- November 2024
- 73 Pages
Global
From €3171EUR$3,495USD£2,733GBP
- Report
- October 2024
- 70 Pages
Global
From €3171EUR$3,495USD£2,733GBP
- Report
- October 2024
- 69 Pages
Global
From €3171EUR$3,495USD£2,733GBP
- Report
- May 2023
- 73 Pages
Global
From €3171EUR$3,495USD£2,733GBP
- Report
- March 2023
- 69 Pages
Global
From €6342EUR$6,990USD£5,465GBP
- Drug Pipelines
- March 2023
- 150 Pages
Global
From €13604EUR$14,995USD£11,724GBP
- Report
- September 2022
- 66 Pages
Global
From €3171EUR$3,495USD£2,733GBP
- Report
- September 2022
- 74 Pages
Global
From €3171EUR$3,495USD£2,733GBP
- Report
- July 2022
- 59 Pages
Global
From €3171EUR$3,495USD£2,733GBP
- Report
- May 2024
- 124 Pages
Global
From €3584EUR$3,950USD£3,088GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more